Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
- PMID: 30191987
- DOI: 10.1002/jcp.27163
Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
Retraction in
-
Retraction.J Cell Physiol. 2022 Mar;237(3):2005. doi: 10.1002/jcp.30517. Epub 2021 Jul 20. J Cell Physiol. 2022. PMID: 34287860
Abstract
Ovarian cancer (OC) is a lethal gynecologic tumor, which brings its mortality to the head. CXCL12 and its receptor chemokine receptor 4 ( CXCR4) have been found to be highly expressed in OC and contribute to the disease progression by affecting tumor cell proliferation and invasion. Here, in this study, we aim to explore whether the blockade of CXCL12-CXCR4 axis with AMD3100 (a selective CXCR4 antagonist) has effects on the progression of OC. On the basis of the gene expression omnibus database of OC gene expression chips, the OC differentially expressed genes were screened by microarray analysis. OC (nonmetastatic and metastatic) and normal ovarian tissues were collected to determine the expressions of CXCL12 and CXCR4. A series of AMD3100, shRNA against CXCR4, and pCNS-CXCR4 were introduced to treat CAOV3 cells with the highest CXCR4 was assessed. Cell viability, apoptosis, migration, and invasion were all evaluated. The microarray analysis screened out the differential expression of CXCL12-CXCR4 in OC. CXCL12 and CXCR4 expressions were increased in OC tissues, particularly in the metastatic OC tissues. Downregulation of CXCR4 by AMD3100 or shRNA was observed to have a critical role in inhibiting cell proliferation, migration, and invasion of the CAOV3 OC cell line while promoting cell apoptosis. Overexpressed CXCR4 brought significantly promoting effects on the proliferation and invasiveness of OC cells. These results reinforce that the blockade of CXCL12-CXCR4 axis with AMD3100 inhibits the growth of OC cells. The antitumor role of the inhibition of CXCL12-CXCR4 axis offers a preclinical validation of CXCL12-CXCR4 axis as a therapeutic target in OC.
Keywords: AMD3100; CXCL12-CXCR4 axis; apoptosis; invasion; migration; ovarian cancer; proliferation.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
[Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):403-7. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17697603 Chinese.
-
Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.PLoS One. 2013;8(1):e51500. doi: 10.1371/journal.pone.0051500. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372646 Free PMC article.
-
Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.Mol Carcinog. 2017 Aug;56(8):1896-1908. doi: 10.1002/mc.22645. Epub 2017 Mar 30. Mol Carcinog. 2017. PMID: 28277622
-
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.Head Neck. 2013 Dec;35(12):1819-28. doi: 10.1002/hed.23217. Epub 2013 Mar 6. Head Neck. 2013. PMID: 23468253 Review.
-
[Correlations of chemokine CXCL12 and its receptor to tumor metastasis].Ai Zheng. 2007 Feb;26(2):220-4. Ai Zheng. 2007. PMID: 17298758 Review. Chinese.
Cited by
-
Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats.Am J Transl Res. 2021 Mar 15;13(3):1458-1470. eCollection 2021. Am J Transl Res. 2021. PMID: 33841670 Free PMC article.
-
CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.Int J Nanomedicine. 2020 Aug 7;15:5701-5718. doi: 10.2147/IJN.S257527. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32848392 Free PMC article.
-
Norcantharidin induces ferroptosis via the suppression of NRF2/HO-1 signaling in ovarian cancer cells.Oncol Lett. 2022 Aug 25;24(4):359. doi: 10.3892/ol.2022.13479. eCollection 2022 Oct. Oncol Lett. 2022. Retraction in: Oncol Lett. 2025 Jan 07;29(3):129. doi: 10.3892/ol.2025.14861 PMID: 36168316 Free PMC article. Retracted.
-
Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.Biomed Res Int. 2021 Mar 19;2021:8883800. doi: 10.1155/2021/8883800. eCollection 2021. Biomed Res Int. 2021. PMID: 33829065 Free PMC article.
-
G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.Int J Mol Sci. 2019 Nov 7;20(22):5568. doi: 10.3390/ijms20225568. Int J Mol Sci. 2019. PMID: 31703453 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical